Rates and characteristics of intracerebral cavernous malformations after cranial radiation therapy remain poorly understood. Herein we report on intracerebral cavernous malformations detected on follow-up imaging in pediatric cancer patients who received cranial radiation therapy at age 18 years from 1980 to 2009. Through chart reviews (n ¼ 362) and phone interviews (n ¼ 104) of a retrospective cohort, we identified 10 patients with intracerebral cavernous malformations. The median latency time for detection of intracerebral cavernous malformations after cranial radiation therapy was 12 years (range 1-24 years) at a median age of 21.4 years (interquartile range ¼ 15-28). The cumulative incidence was 3% (95% confidence interval 1%-8%) at 10 years post cranial radiation therapy and 14% (95% confidence interval 7%-26%) at 15 years. Three patients underwent surgical resection. Two surgical specimens were pathologically similar to sporadically occurring intracerebral cavernous malformations; one was consistent with capillary telangiectasia. Intracerebral cavernous malformations are common after cranial radiation therapy and can show a spectrum of histologic features.
Intracerebral cavernous malformations are increasingly recognized as one of the long-term sequelae of cranial radiation therapy, especially in pediatric populations. [1] [2] [3] [4] [5] Although the majority of these intracerebral cavernous malformations are asymptomatic, symptomatic lesions can present with seizure, new headache, and focal neurologic deficits due to hemorrhagic stroke. Pathologically, intracerebral cavernous malformations are characterized by a circumscribed cluster of dilated vascular sinusoids lined by a single endothelial layer, with little to no intervening brain parenchyma. [1] [2] [3] [4] [5] Intralesional or perilesional deposits, including thrombus, calcification, and cysts are common, and intracerebral cavernous malformations are often bordered by hemosiderin and reactive gliosis. On magnetic resonance imaging (MRI), intracerebral cavernous malformations present as mixed-signal lesions of low and high intensity surrounded by a complete rim of T1 hypointensity. This ''popcorn'' appearance corresponds to the mixture of blood products at various stages of degradation within and around the lesion.
The prevalence of intracerebral cavernous malformations has been reported to be 0.4% to 0.6% in the general population; however, the incidence of intracerebral cavernous malformations after cranial radiation therapy remains largely unknown. [6] [7] [8] [9] A few studies have reported that intracerebral cavernous malformations occur within the field of prior radiation as early as 5 months, with the majority occurring 3 to 10 years after cranial radiation therapy. 1, 4 The precise relationship between cranial radiation therapy dose and intracerebral cavernous malformation development, however, is still unclear. Some studies have found a dose-dependent relationship noting decreased latency to intracerebral cavernous malformation development in those who receive higher radiation doses. 1, 5, 10 Others report an inverse relationship, finding that intracerebral cavernous malformations occur more commonly at the lower dose rim of the radiation field. 5, 11 Regardless, it appears that low-dose radiation is sufficient to induce intracerebral cavernous malformations, as children with leukemia, who are treated with relatively low doses of radiation (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , are also at increased risk for developing intracerebral cavernous malformations. 11, 12 There are conflicting reports as to whether radiationinduced intracerebral cavernous malformations differ pathologically from congenital/spontaneously occurring intracerebral cavernous malformations. 1, [13] [14] [15] [16] Clinically, radiation-induced intracerebral cavernous malformations also appear to carry an increased risk of hemorrhage, reported at 3.9% per patientyear as compared to 0.25% in spontaneous intracerebral cavernous malformations. 5, 7 In this study, we assessed the incidence of radiographically detected intracerebral cavernous malformations in a singlecenter retrospective cohort of patients who received cranial radiation therapy during childhood. When available, we reviewed pathology in order to further characterize the histologic features of radiation-induced intracerebral cavernous malformations.
Materials and Methods
We performed a retrospective cohort study of patients identified through the University of California, San Francisco (UCSF) Cancer Registry who received treatment at UCSF with cranial radiation therapy at age 18 years between 1980 and 2009. This cohort was previously described. 17 We identified 385 eligible patients whom we contacted through mail and invited to participate in the study. Twenty-three patients declined and were excluded from the study. Chart review was conducted for the remaining 362 patients, and of those, 104 (or surrogates when necessary) consented/assented to telephone interviews. Interviews were carried out with either the patient (if alive and aged 18 years at the time of the study; n ¼ 71), or the legal guardian of the patients currently aged <18 years (n ¼ 20), or deceased (n ¼ 13). Information gathered during chart review and/or interview included baseline demographics (age, sex, race), primary cancer diagnosis and cancer treatment, age and date of diagnosis, radiation dose and treatment time, date of initial MRI to detect primary cancer diagnosis, and date of last MRI follow-up at our institution. Primary cancer diagnosis was based on pathology report, and date of surgery was confirmed by operative report. Intracerebral cavernous malformation identified by chart review was defined as physician documentation of intracerebral cavernous malformation and/or brain imaging report that indicated intracerebral cavernous malformation. Nine intracerebral cavernous malformation patients were identified by chart review. Intracerebral cavernous malformation identified by interview was defined as participant report of a healthcare provider communicating the diagnosis to the patient. One intracerebral cavernous malformation patient was identified on interview, and the patient's diagnosis was subsequently confirmed by chart and imaging review. For all patients with a diagnosis of intracerebral cavernous malformation, all relevant brain imaging was obtained and reviewed by a study neuroradiologist (CH), who confirmed presence or absence of intracerebral cavernous malformation, and specified anatomic locations for each intracerebral cavernous malformation. For patients with intracerebral cavernous malformation, additional information gathered by chart review included interval timing of imaging follow-up after cranial radiation therapy, and intracerebral cavernous malformation-related symptoms or treatment. Pathology specimens were obtained and reviewed in detail by a trained pathologist (JC) for all patients who underwent resection of the intracerebral cavernous malformation. Data from medical records and imaging for all patients, including those who did not have intracerebral cavernous malformations, were collected through September 2011.
Statistical Analysis
Survival analysis was used to determine cumulative incidence of radiographically defined intracerebral cavernous malformation after cranial radiation therapy. The primary outcome was time to radiographic appearance of intracerebral cavernous malformation, calculated from the last day of cranial radiation therapy to the date of first MRI with evidence of intracerebral cavernous malformation. Censoring criteria were death, evidence of intracerebral cavernous malformation, or last follow-up MRI without evidence of intracerebral cavernous malformation. For all patients with evidence of intracerebral cavernous malformation, we confirmed that initial diagnostic imaging and follow-up MRI after completion of cranial radiation therapy was negative for intracerebral cavernous malformation until date of diagnosis. Most patients were followed with MRI scans at regular time intervals, every 1 to 2 years. To calculate incidence rates we used the midpoint of the interval between cranial radiation therapy/last normal MRI and first detection. For 2 patients who did not receive regular MRI follow-up, the median time between end of cranial radiation therapy and date of initial radiographic evidence of intracerebral cavernous malformation was used as an estimate for our analysis. Because our primary goal was to estimate incidence and not to determine factors associated with time to occurrence of intracerebral cavernous malformation, we did not account for the fact that our data were interval censored, given that actual time of intracerebral cavernous malformation development cannot be known. Rather, we used detection date to calculate incidence rates.
Results

Patient Characteristics
Of the 362 eligible patients, we excluded 123 given that these patients had no MRI after completion of radiation therapy (Figure 1 , Supplemental Table 1 ). For the 239 patients, median age at time of cranial radiation therapy was 8.7 years (interquartile range ¼ 4.6-13.0), and median age at last follow-up was 15.1 years (interquartile range ¼ 9.6-19.3). The majority of the patients were alive (n ¼ 165; 69%) at the time of interview and/or chart review (Tables 1 and 2) .
Radiographically Detected Intracerebral Cavernous Malformation
In our cohort of 239 participants, we identified 10 patients with a diagnosis of intracerebral cavernous malformation and all were confirmed radiographically. Figures 2 and 3 show representative MRI images of confirmed intracerebral cavernous malformations, revealing well-circumscribed lesions with heterogeneous T1 and T2 signal, with surrounding hemosiderin and varying degrees of calcification and gliosis. Of the 10 identified patients with intracerebral cavernous malformations, 8 had had MRI follow-up every 1 to 2 years from the time of their cranial radiation therapy to their intracerebral cavernous malformation diagnosis, whereas 2 patients were lost to followup after their initial cranial radiation therapy. These 2 patients underwent MRI more than 10 years after completion of cranial radiation therapy, at which time intracerebral cavernous malformation was noted on imaging.
Baseline demographics of the patients with intracerebral cavernous malformations show that most were male (n ¼ 8; 80%). Nine of 10 patients with intracerebral cavernous malformations received cranial radiation therapy doses >50 Gy (range 54-66 Gy) and 1 patient received low-dose cranial radiation therapy of 24 Gy. Seven of the 10 intracerebral cavernous malformations were located within the brain region that received high-dose cranial radiation therapy whereas the remaining 3 were located in the periphery of the radiation field ( Table 2) . Median age at cranial radiation therapy was 9.7 years (interquartile range ¼ 7.9-13.7) and median latency of intracerebral cavernous malformation diagnosis (defined as time from cranial radiation therapy to midpoint between last cavernous malformation-free MRI and cavernous malformation diagnosis MRI) was 11.6 years post cranial radiation therapy (interquartile range ¼ 4.3-12.8) ( Figure 4 ). Median latency decreases slightly to 9.0 if the 2 children with long intervals between last cavernous malformation-free MRI and cavernous malformation diagnosis MRI are excluded, but interquartile ranges for this latency period remain largely unchanged (3.9-12.6). The overall rate of radiographically detected intracerebral cavernous malformation was 584 per 100 000 person-years (95% confidence interval 538-633). The cumulative incidence of radiographically detected intracerebral cavernous malformation was 2% (95% confidence interval 0.6%-6%) at 5 years, 3% (95% confidence interval 1%-8%) at 10 years, and 14% (95% confidence interval 7%-26%) at 15 years.
Characteristics of Intracerebral Cavernous Malformation on Pathology
Of the 10 patients with radiographically detected intracerebral cavernous malformations, 3 patients underwent surgical resection for symptoms attributed to these lesions. Symptoms included new onset of headache plus seizures (patient 4), worsening headache (patient 5), and left-sided numbness, left facial droop, left visual field defect, and decreased strength on the left side (patient 10). Two patients had resection specimens that were morphologically similar to spontaneously occurring or congenital intracerebral cavernous malformations. These specimens demonstrated thin-walled dilated loops of nonarterial vessels with little to no intervening brain tissue, and adjacent hemosiderin-laden macrophages. The third specimen exhibited characteristics of a telangiectasia, with smaller, capillary-like vascular lumina separated by intervening brain parenchyma (Figure 3 ).
Discussion
In this single-center retrospective cohort study, we found that children undergoing cranial radiation therapy for cancer therapy are at high risk for developing intracerebral cavernous malformations years after their initial therapy. Symptomatic radiation-induced intracerebral cavernous malformations that are classified as such on imaging represent a spectrum of vascular disorders on histology ranging from capillary telangiectasia to a more classic intracerebral cavernous malformation appearance. The cumulative incidence of intracerebral cavernous malformations after cranial radiation therapy has been estimated at 3.9% and 5.0% within 10 and 15 years post cranial radiation therapy, respectively. 3 In our cohort of pediatric cancer patients treated with cranial radiation therapy, the cumulative incidence of post-cranial radiation therapy intracerebral cavernous malformation was found to be slightly higher at 3% at 10 years and 14% at 15 years; however, because of our small sample number, the 95% confidence intervals are relatively large, and that difference might not be statistically significant. Not all patients in our cohort, however, underwent imaging most sensitive to intracerebral cavernous malformation detection, such as gradient echo imaging at high field strengths. Some intracerebral cavernous malformations may therefore have remained undetected, and our results likely underestimate the true incidence in this cohort.
Our study period spanned 29 years, and most cases of intracerebral cavernous malformation were documented in the last 10 years of the study, with the majority of intracerebral cavernous malformations documented in the last 5 years of the study. Although there is literature reporting radiographic identification of intracerebral cavernous malformations decades before the onset of our study period, the identified intracerebral cavernous malformations in the later years of our study could reflect the significant evolution in imaging technology, or even an increased awareness of intracerebral cavernous malformations among radiologists. Hence, these are additional factors that could have potentially contributed to underreporting of intracerebral cavernous malformations in the earlier years of the study.
Radiation-induced intracerebral cavernous malformations are known to develop over a long time period after cranial radiation therapy: in our cohort, 1 to 24 years after radiation. The median latency time to detection was 9 years; however, imaging was not done systematically at specific time points for all patients, so the exact latency could not be determined. Prior reports have estimated very similar latency times, ranging from 3 months to 22 years. 11, 16, 18 These results suggest that pediatric cancer patients treated with cranial radiation therapy who present with new neurologic findings should also be assessed for intracerebral cavernous malformations as a potential underlying diagnosis.
Young age at time of cranial radiation therapy has been associated with an increased risk of developing intracerebral cavernous malformations. 1, 2, 5 Vinchon et al, however, reported that receiving cranial radiation therapy at an older age was a risk factor for developing intracerebral cavernous malformations. 19 In our cohort, 7 children were 12 years of age at time of cranial radiation therapy, whereas only 3 were treated with cranial radiation therapy at age >12 years. Although the rate of intracerebral cavernous malformation detection per 100 000 person-years did not significantly differ between the <12 years age group (595, 95% confidence interval 548-644, n ¼ 7) and the >12 years group (559, 95% confidence interval 514-607, n ¼ 3), given the small sample size of the groups, we cannot rule out the possibility that we lacked the power to detect a true difference.
Vascular malformations after cranial radiation therapy can exhibit heterogenous histopathology. A study by Baumgartner et al found that radiation-induced intracerebral cavernous malformations are pathologically identical to sporadic and familial intracerebral cavernous malformations. 16 However, as Pozzatti et al note, naturally occurring intracerebral cavernous malformations usually display elements that suggest a prolonged development, including calcification. 20 In our study, 2 of the 3 pathologic specimens showed classic appearance of intracerebral cavernous malformations and had no evidence of calcifications, whereas the other specimen was consistent with telangiectasia with evidence of calcifications. Although the pathogenesis of radiation-induced intracerebral cavernous malformations is not well understood, it has been proposed that they result from radiation-induced injury to the vasculature that histologically manifests as fibrinoid necrosis, hyalinization, and edema. Such changes can cause narrowing of the vascular lumen, leading to ischemia and the release of angiogenic factors, thus inducing dilation and proliferation of thin-walled vessels in adjacent areas. 21 Although intracerebral cavernous malformation and capillary telangiectasia are considered separate, pathologically defined entities, they can have a similar imaging appearance, and some authors have proposed that they may be part of the same disease spectrum, representing early and late phases of radiation-induced vasculopathy, respectively. 22 Although our sample size is small, our results are consistent with prior observations of pathological variation among radiographically detected intracerebral cavernous malformations.
Eight of our 10 radiographically detected intracerebral cavernous malformations were found in male patients. This male predominance is supported by a review of the literature of radiation-induced intracerebral cavernous malformations and other small case series. 4, 11 However, others have found no gender predilection in the development of intracerebral cavernous malformations after cranial radiation therapy. 18 More studies with greater numbers are needed to assess whether a gender predilection is present in the risk of intracerebral cavernous malformation development following cranial radiation therapy.
In our study, 9 of 10 patients with intracerebral cavernous malformation had a cranial radiation therapy dose of >30 Gy, suggesting that higher cranial radiation therapy doses may confer an increased risk of developing intracerebral cavernous malformation. Our results are supported by multiple prior studies reporting an association between cranial radiation therapy dose >30 Gy and increased intracerebral cavernous malformation incidence. 3, 4, 11 Similarly, our cohort reflects previously published data that most cranial radiation therapyassociated intracerebral cavernous malformations are asymptomatic, 3, 12 as only 3 of our 10 radiographically detected intracerebral cavernous malformations required surgical intervention for symptom control.
It has been reported that risk of hemorrhage may be significant among pediatric patients with cranial radiation therapyinduced intracerebral cavernous malformations. 11 However, no patients in our cohort presented with or subsequently developed a symptomatic hemorrhage during our follow up period. In 1 study, among 419 patients who received cranial radiation therapy, 9 developed intracerebral cavernous malformations and 3 of those developed symptomatic hemorrhagic intracerebral cavernous malformations requiring surgical intervention. 11 By contrast, the rate of symptomatic hemorrhage in sporadically occurring intracerebral cavernous malformations in the general population is only 2.4% per patient-year. 6 Studies showing a higher bleeding risk for cranial radiation therapy-induced intracerebral cavernous malformations had small cohorts of 6 to 9 patients with intracerebral cavernous malformations; therefore, larger, prospective studies are needed to further clarify this risk.
Conclusion
Radiation-induced intracerebral cavernous malformations are frequent in patients who have undergone cranial radiation therapy and occur on a histopathologic spectrum.
